1-2 of 2
Martin Cullell-Young
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Antitumor Activity of Lurbinectedin, a Selective Inhibitor of Oncogene Transcription, in Patients with Relapsed Ewing Sarcoma: Results of a Basket Phase II Study

Vivek Subbiah, Irene Braña, Alessandra Longhi, Valentina Boni, Jean-Pierre Delord, Ahmad Awada, Pascaline Boudou-Rouquette, John Sarantopoulos, Geoffrey I. Shapiro, Anthony Elias, Ravin Ratan, Cristian Fernandez, Carmen Kahatt, Martin Cullell-Young, Mariano Siguero, Ali Zeaiter, Sant P. Chawla
Journal: Clinical Cancer Research
Clin Cancer Res OF1–OF9.
DOI: https://doi.org/10.1158/1078-0432.CCR-22-0696
Published: 20 May 2022
View article
PDF
Journal Articles

First-In-Human Phase I Study of Lurbinectedin (PM01183) in Patients with Advanced Solid Tumors

María Elena Elez, Josep Tabernero, David Geary, Teresa Macarulla, S. Peter Kang, Carmen Kahatt, Arturo Soto-Matos Pita, Carlos Fernandez Teruel, Mariano Siguero, Martin Cullell-Young, Sergio Szyldergemajn, Mark J. Ratain
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (8): 2205–2214.
DOI: https://doi.org/10.1158/1078-0432.CCR-13-1880
Published: 15 April 2014
View article
PDF